📚 Our findings contribute to a deeper understanding of schizophrenia biology and pave the way for more targeted therapies and interventions. Stay tuned for updates on our cognitive genomics research! #Schizophrenia#Pleiotropy#MedRxiv#NIMH
🧬 New preprint alert! Our latest manuscript on MedRxiv investigates the complex pleiotropic genetic landscape of schizophrenia, cognitive function and educational attainment uncovering 768 significant loci – 159 of which are novel. https://t.co/9OJAX9cGrL @ToddLencz
🔬 Our new results dissociate forebrain and hindbrain neurodevelopmental processes, and implicate translation initiation factors in schizophrenia pathophysiology for the first time.
We are looking forward to 2024 WCPG in Singapore (15th-19th Oct). In the words of our 2024 Program Chairs, "These are exciting times in psychiatric genetics."
Want to learn more? Check out the 2024 invitation to attend: https://t.co/fF65QxeUtm
#psychiatry#genetics
🤩 OUT TODAY @NatureGenet
📰 The Singapore National Precision Medicine Strategy
👩🏾🤝👨🏽 John C. Chambers, E. Shyong Tai, Patrick Tan and team
👇🏿🇸🇬🧬👇🏿
https://t.co/FdbC6JnvHI
Glad to share this manuscript https://t.co/qPLfq6adF9 which is finally out in @molpsychiatry. Previous studies identified immune gene dysregulations in the brains of patients with several major brain disorders. (1/7)
New manuscript @NatureComms! We leveraged data from 19 cognitive GWAS to disentangle biological mechanisms underlying psychopathology (17 psychiatric GWAS). Some updates from the previous tweetorial! (1/8)
The results might provide insights into the potential of nootropic agents targeting specific biological mechanisms to alleviate functional disability within psychopathology. (8/8)